GSA Capital Partners’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
283,812
+268,650
| +1,772% | +$1.21M | 0.09% | 318 |
|
|
2025
Q1 | $70K | Buy |
+15,162
| New | +$70K | 0.01% | 1533 |
|
|
2024
Q3 | – | Sell |
-25,346
| Closed | -$95K | – | 1757 |
|
|
2024
Q2 | $95K | Buy |
+25,346
| New | +$95K | 0.01% | 1531 |
|
|
2022
Q4 | – | Sell |
-19,084
| Closed | -$156K | – | 1624 |
|
|
2022
Q3 | $156K | Buy |
+19,084
| New | +$156K | 0.02% | 1286 |
|